Wataru Inaba

566 total citations
17 papers, 468 citations indexed

About

Wataru Inaba is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Wataru Inaba has authored 17 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Molecular Biology. Recurrent topics in Wataru Inaba's work include Pancreatic function and diabetes (9 papers), Metabolism, Diabetes, and Cancer (6 papers) and Diabetes and associated disorders (5 papers). Wataru Inaba is often cited by papers focused on Pancreatic function and diabetes (9 papers), Metabolism, Diabetes, and Cancer (6 papers) and Diabetes and associated disorders (5 papers). Wataru Inaba collaborates with scholars based in Japan. Wataru Inaba's co-authors include Soroku Yagihashi, Hiroki Mizukami, Sho Osonoi, Kazunori Takahashi, Noriaki Kato, Masayuki Baba, Yuki Takeuchi, Xin An, Hitoshi Sugihara and Mototsugu Nagao and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Wataru Inaba

17 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wataru Inaba Japan 11 244 170 137 105 79 17 468
Ji-Won Kim South Korea 15 362 1.5× 208 1.2× 197 1.4× 134 1.3× 84 1.1× 34 612
Cecilia Vitali United States 9 258 1.1× 166 1.0× 153 1.1× 48 0.5× 64 0.8× 25 567
Gemma L. Pearson United States 10 228 0.9× 77 0.5× 167 1.2× 68 0.6× 164 2.1× 16 447
Vaibhav Sidarala United States 10 210 0.9× 76 0.4× 221 1.6× 83 0.8× 81 1.0× 19 399
Hidemitsu Sakagami Japan 8 182 0.7× 206 1.2× 206 1.5× 65 0.6× 36 0.5× 13 515
Liora S. Katz United States 17 345 1.4× 171 1.0× 331 2.4× 175 1.7× 97 1.2× 28 737
Matthew C. Cane United Kingdom 9 299 1.2× 67 0.4× 155 1.1× 71 0.7× 68 0.9× 9 434
Sabine Rütti Switzerland 11 329 1.3× 247 1.5× 230 1.7× 130 1.2× 147 1.9× 16 678
Timothy M. Mason Canada 9 142 0.6× 181 1.1× 141 1.0× 165 1.6× 67 0.8× 10 482
Nadia Cobo‐Vuilleumier Spain 17 316 1.3× 253 1.5× 285 2.1× 198 1.9× 64 0.8× 30 721

Countries citing papers authored by Wataru Inaba

Since Specialization
Citations

This map shows the geographic impact of Wataru Inaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wataru Inaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wataru Inaba more than expected).

Fields of papers citing papers by Wataru Inaba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wataru Inaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wataru Inaba. The network helps show where Wataru Inaba may publish in the future.

Co-authorship network of co-authors of Wataru Inaba

This figure shows the co-authorship network connecting the top 25 collaborators of Wataru Inaba. A scholar is included among the top collaborators of Wataru Inaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wataru Inaba. Wataru Inaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mizukami, Hiroki, Sho Osonoi, Kazuhisa Takahashi, et al.. (2019). Normal High HbA1c a Risk Factor for Abnormal Pain Threshold in the Japanese Population. Frontiers in Endocrinology. 10. 651–651. 10 indexed citations
2.
Mizukami, Hiroki, Kazuhisa Takahashi, Sho Osonoi, et al.. (2018). Synergistic Effects of Long-Term Combination Therapy of DPP-4 Inhibitor and SGLT2 Inhibitor on the Preservation of Beta-Cell Volume in Rats with Type 2 Diabetes. Diabetes. 67(Supplement_1). 1 indexed citations
3.
Saito, Takeshi, Hiroki Mizukami, Wataru Inaba, et al.. (2017). Worsened outcome in patients with pancreatic ductal carcinoma on long-term diabetes: association with E-cadherin1 (CDH1) promoter methylation. Scientific Reports. 7(1). 12 indexed citations
4.
An, Xin, et al.. (2017). Pancreas Atrophy and Islet Amyloid Deposition in Patients With Elderly-Onset Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 102(9). 3162–3171. 27 indexed citations
5.
6.
Maeda, Shugo, Eiichi Tsuda, Hiroki Mizukami, et al.. (2015). Histological evaluation of low-intensity pulsed ultrasound on osteochondritis dissecans of the humeral capitellum. Asia-Pacific Journal of Sports Medicine Arthroscopy Rehabilitation and Technology. 2(2). 56–62. 2 indexed citations
7.
Yagihashi, Soroku, Wataru Inaba, & Hiroki Mizukami. (2015). Dynamic pathology of islet endocrine cells in type 2 diabetes: β‐Cell growth, death, regeneration and their clinical implications. Journal of Diabetes Investigation. 7(2). 155–165. 41 indexed citations
8.
Nagao, Mototsugu, Akira Asai, Wataru Inaba, et al.. (2014). Characterization of Pancreatic Islets in Two Selectively Bred Mouse Lines with Different Susceptibilities to High-Fat Diet-Induced Glucose Intolerance. PLoS ONE. 9(1). e84725–e84725. 26 indexed citations
9.
Mizukami, Hiroki, et al.. (2014). Islet amyloid with macrophage migration correlates with augmented β-cell deficits in type 2 diabetic patients. Amyloid. 21(3). 191–201. 78 indexed citations
10.
11.
Yagihashi, Soroku, Hiroki Mizukami, & Wataru Inaba. (2014). Quo vadis: Where have the β‐cells gone?. Journal of Diabetes Investigation. 6(4). 393–395. 1 indexed citations
12.
Furukawa, Ken‐Ichi, Atsushi Ono, Toru Asari, et al.. (2013). Immunohistochemical localization of mesenchymal stem cells in ossified human spinal ligaments. Biochemical and Biophysical Research Communications. 436(4). 698–704. 27 indexed citations
13.
14.
Mizukami, Hiroki, et al.. (2013). Age‐associated changes of islet endocrine cells and the effects of body mass index in Japanese. Journal of Diabetes Investigation. 5(1). 38–47. 42 indexed citations
15.
16.
Inaba, Wataru, et al.. (2012). Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats. European Journal of Pharmacology. 691(1-3). 297–306. 26 indexed citations
17.
Mizukami, Hiroki, et al.. (2011). Augmented reduction of islet β‐cell mass in Goto‐Kakizaki rats fed high‐fat diet and its suppression by pitavastatin treatment. Journal of Diabetes Investigation. 3(3). 235–244. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ji-Won Kim Breakdown of academic impact, for papers by Cecilia Vitali Breakdown of academic impact, for papers by Gemma L. Pearson Breakdown of academic impact, for papers by Vaibhav Sidarala Breakdown of academic impact, for papers by Hidemitsu Sakagami Breakdown of academic impact, for papers by Liora S. Katz Breakdown of academic impact, for papers by Matthew C. Cane Breakdown of academic impact, for papers by Sabine Rütti Breakdown of academic impact, for papers by Timothy M. Mason Breakdown of academic impact, for papers by Nadia Cobo‐Vuilleumier
Rankless by CCL
2026